OSM Industry Intel • Spring 2026 Muscle Is Not Just for Lifting. It Is an Endocrine Organ, and That Changes the Whole Supplement Pitch. A comprehensive June 2026 review reframes skeletal muscle as a context-sensitive signaling organ that pumps out chemical messengers called myokines, talking directly to the liver, bone, brain, and fat. The opportunity […]
Learn More
OSM Industry Intel • Spring 2026 A Trace Mineral Just Became the Most Interesting Story in Brain Aging. And One Specific Form Steals the Show. A landmark 2025 study in Nature found that one mineral, and only one, was selectively depleted in the brains of people with cognitive decline: lithium. The plot twist involves amyloid […]
Learn More
OSM Industry Intel • 2026 The Apigenin Story Just Got More Interesting: A Common Flavonoid That Raises Cellular NAD+ A peer-reviewed study shows the plant flavonoid apigenin inhibits CD38, the enzyme that quietly burns through your NAD+ supply. For brands building longevity and metabolic SKUs, this is a mechanism worth understanding. NAD+ has been having […]
Learn More
OSM Industry Intel • Spring 2026 Your Customers’ Mouthwash Might Be Raising Their Blood Pressure. That Is a Supplement Opportunity. A review in the Journal of Dental Research lays out how bacteria on the back of the tongue convert dietary nitrate into the raw material for nitric oxide, and how killing those bacteria removes up […]
Learn More